Natural killer cells and anti-tumor immunity
SE Nicholson, N Keating, GT Belz - Molecular immunology, 2019 - Elsevier
Immune checkpoint inhibitors harness the power of the immune system to fight cancer. The
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …
Natural killer cells and anti-tumor immunity
SE Nicholson, N Keating… - Molecular immunology, 2019 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors harness the power of the immune system to fight cancer. The
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …
Natural killer cells and anti-tumor immunity.
SE Nicholson, N Keating, GT Belz - Molecular Immunology, 2017 - europepmc.org
Immune checkpoint inhibitors harness the power of the immune system to fight cancer. The
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …
[引用][C] Natural killer cells and anti-tumor immunity
SE Nicholson, N Keating, GT Belz - Molecular Immunology, 2019 - espace.library.uq.edu.au
Immune checkpoint inhibitors harness the power of the immune system to fight cancer. The
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …
clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and …